Diagnostics: Page 26


  • Transmission electron micrograph of a SARS-CoV-2 virus particle, isolated from a patient.
    Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Image]. Retrieved from Flickr.
    Image attribution tooltip

    Thermo Fisher, Hologic ride wave of COVID-19 test demand, for now

    The two lateral flow assay companies reported strong coronavirus testing sales in the latest quarter. However, Hologic CFO Karleen Oberton told investors late Monday the pandemic remains unpredictable.

    By Nov. 2, 2021
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Siemens' Varian leads latest FDA breakthrough device designations

    Varian secured the regulatory privileges for its noninvasive treatment of knee osteoarthritis based on technology acquired from Boston Scientific. Magnus Medical, Renovia and MY01 are included in the latest batch of designations.

    By Nov. 1, 2021
  • Close up of hand touching smartwatch with health app on the screen. Explore the Trendline
    Image attribution tooltip
    Sitthiphong via Getty Images
    Image attribution tooltip
    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

    By MedTech Dive staff
  • Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA, global peers create guiding principles for AI/ML medical devices

    The U.S., U.K. and Canada are seeking international harmonization as part of a broader discussion on the development of safe, effective devices that use artificial intelligence and machine learning.

    By Oct. 29, 2021
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA's 2022 A-list guidance plan hits on software, post-pandemic future

    The agency's priorities include a much-anticipated final guidance on clinical decision support software — more than five years in the making — meant to clarify when CDS meets the definition of a medical device.

    By Oct. 27, 2021
  • Notified bodies join chorus of criticism of proposed European AI regs

    Team-NB has come out strongly against the regulation, arguing it will add to administrative burdens, reduce notified body capacity and create confusion.

    By Oct. 26, 2021
  • Amazon officials speak at HLTH 2021
    Image attribution tooltip
    Rebecca Pifer/MedTech Dive
    Image attribution tooltip

    Amazon teases 5 more cities to get virtual Amazon Care offering this year

    Amazon Care is currently live in the Washington, D.C. and Baltimore area, and will be rolled out in Dallas, Chicago, Philadelphia, Boston and Los Angeles this year, the unit's director told the HLTH conference this week.

    By Rebecca Pifer • Oct. 22, 2021
  • A picture of the street sign stating "Wall Street." American flags drape over a nearby building
    Image attribution tooltip
    Kena Betancur via Getty Images
    Image attribution tooltip

    Abbott, Intuitive, J&J set tone for earnings: Testing up, procedures down

    The medtechs in recent days confirmed the mixed financial impact of the delta wave and early signs of recovery in elective procedures in the U.S. Reports from Boston Scientific and Stryker come next week.

    By Oct. 21, 2021
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott COVID-19 sales rebound, but calls market too volatile for 2022 forecast

    CEO Robert Ford warned investors that despite a big uptick driven by the delta surge, "we'll have to update on a rolling quarterly basis."    

    By Oct. 20, 2021
  • A picture of the exterior of the US Department of Health and Human Services. In front of the building is a black sign designating the building's name.
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    In last ditch plea to save MCIT, medtech groups suggest fixes to CMS

    AdvaMed and MDMA responded to a call for feedback on the planned repeal of the Medicare Coverage of Innovative Technology pathway by proposing tweaks and new ideas to salvage it.

    By Oct. 20, 2021
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott software causing COVID-19 test false positives, starts Class I recall fix

    FDA said use of the tests before the problem is corrected may cause serious adverse health consequences or death, alerting laboratories to treat the results as presumptive and that they may need to be confirmed with another test.

    By Oct. 19, 2021
  • The European Commission has caved to pressure on extending IVDR. Now what?

    The EC's proposal creates a new set of timelines for the industry to meet and questions to consider — assuming it passes into law without further changes.  

    By Oct. 15, 2021
  • Medtronic pledges R&D boost, brand refresh, amid rising Big Tech rivalry

    CEO Geoff Martha said the device giant is still "building out that direct-to-consumer muscle" and acknowledged "healthy competition" with the likes of Apple and Google.

    By Oct. 14, 2021
  • EU proposes to delay IVD Medical Device Regulation, citing COVID-19 backlog

    Originally set to go into effect in May 2022, a progressive rollout is now planned. The proposal will now go to the European Parliament and Council for adoption, according to the announcement.

    By Kim Dixon • Updated Oct. 14, 2021
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA breakthrough nods go to liquid biopsies for Alzheimer's, cancer drug response

    The agency gave the designation to Quanterix's blood test, which has the potential to aid evaluation of people who present with cognitive impairment, and Nonagen Bioscience's non-invasive bladder cancer test.

    By Oct. 12, 2021
  • Close-up view of a row of $100 bills
    Image attribution tooltip
    Mark Wilson via Getty Images
    Image attribution tooltip

    4 takeaways from a bumper year of M&A medtech activity (so far)

    After hunkering down last year, many companies entered 2021 with large cash reserves and acquisition targets that included players lacking scale to weather the downturn.

    By Oct. 11, 2021
  • Image attribution tooltip
    Permission granted by Quidel Corporation
    Image attribution tooltip

    Quidel hikes revenue forecast, riding COVID-19 testing wave

    CEO Doug Bryant cautioned that "demand can change very quickly," while Craig-Hallum analysts said future coronavirus-related sales remain "unforecastable."

    By Oct. 8, 2021
  • Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient.
    Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Micrograph]. Retrieved from Flickr.
    Image attribution tooltip

    Labcorp, PerkinElmer latest to target COVID-flu combo test market

    FDA gave a nod to Labcorp's diagnostic, which uses a Roche test for SARS-CoV-2, influenza A and influenza B. PerkinElmer's assay also got emergency authorization for those three viruses as well as respiratory syncytial virus.  

    By Oct. 7, 2021
  • Medtechs opened 2021 with a flurry of M&A and have not stopped spending since

    With deals ranging from tuck-ins to multibillion-dollar takeovers, here's a roundup of the M&A spree so far this year after activity came to a near halt amid the unpredictability of 2020.

    Oct. 7, 2021
  • Image attribution tooltip
    Courtesy of Ellume Health
    Image attribution tooltip

    FDA labels Ellume's recent COVID-19 Home Test recall Class I event

    The agency said there have been 35 reports of false positive results but no deaths reported. More than 2.2 million devices are being recalled in the U.S.

    By Updated Nov. 10, 2021
  • Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient
    Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Micrograph]. Retrieved from Flickr.
    Image attribution tooltip

    Acon gets FDA nod for home COVID-19 test kit amid surging US demand

    The diagnostics maker secured authorization for its over-the-counter antigen test amid a nationwide testing shortage. Abbott and Quidel are scaling up production but it could take months to boost output.

    By Oct. 5, 2021
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA's real-world evidence push hampered by data challenges, 'million-dollar question'

    While the agency wants to tap information like electronic health records and wearables to make pre- and postmarket decisions, these sources do not have the same quality controls as clinical trials. 

    By Oct. 4, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA hits nearly all MDUFA IV commitments despite pandemic disruptions

    The main black mark in an audit was the failure to publish draft guidance on content for premarket submissions for software in a medical device.

    By Oct. 4, 2021
  • MedTech Europe director warns about EU's turbulent switch to IVDR

    Oliver Bisazza told the AdvaMed conference this week that while the European Union will "needlessly lose a great deal of tests" in the transition to the In Vitro Diagnostic Regulation, he is confident decision makers will "course correct."

    By Sept. 30, 2021
  • Amid pandemic, medtech R&D, merger activity jumped: EY report

    Research and development spending at pure-play medtechs rose to a level last seen before the 2007-2008 financial crisis.

    By Sept. 27, 2021
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    Cue, Google's COVID-19 test provider, raises $200M in IPO

    The at-home test maker will use the money to scale up commercial and manufacturing infrastructure to support its portable diagnostic platform. Cue Health's Friday debut on the Nasdaq valued the company at $2.9 billion.

    By Sept. 27, 2021